Abstract
Systemic amyloid light chain (AL) amyloidosis is a severe disease with unfavourable prognosis. Since the late 1970s different therapeutic modalities in AL amyloidosis have been investigated, trying to prolong survival. This review deals with the therapeutic modalities in AL amyloidosis to date, and highlights future perspectives.
| Original language | English |
|---|---|
| Pages (from-to) | 106-113 |
| Number of pages | 8 |
| Journal | Netherlands Journal of Medicine |
| Volume | 62 |
| Issue number | 4 |
| Publication status | Published - Apr-2004 |
Keywords
- STEM-CELL TRANSPLANTATION
- HIGH-DOSE MELPHALAN
- MULTIPLE-MYELOMA
- P COMPONENT
- LIGHT-CHAINS
- SERUM
- SURVIVAL
- TRIAL
- CHEMOTHERAPY
- THALIDOMIDE